阿片类药物使用障碍患者保留和药物使用的预测因素转移到专业“第二次机会”美沙酮计划。

IF 2 Q3 SUBSTANCE ABUSE Substance Abuse: Research and Treatment Pub Date : 2022-01-01 DOI:10.1177/11782218221138335
Tabitha E Moses, Gary L Rhodes, Emytis Tavakoli, Carl W Christensen, Alireza Amirsadri, Mark K Greenwald
{"title":"阿片类药物使用障碍患者保留和药物使用的预测因素转移到专业“第二次机会”美沙酮计划。","authors":"Tabitha E Moses,&nbsp;Gary L Rhodes,&nbsp;Emytis Tavakoli,&nbsp;Carl W Christensen,&nbsp;Alireza Amirsadri,&nbsp;Mark K Greenwald","doi":"10.1177/11782218221138335","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Many patients in methadone treatment have difficulty achieving or maintaining drug abstinence, and many clinics have policies that lead to discharging these patients. We designed a pilot \"Second Chance\" (SC) program for patients scheduled to be discharged from other local methadone clinics to be transferred to our clinic.</p><p><strong>Aim: </strong>Determine whether SC patients' retention and opioid use is related to physical or mental health conditions, non-opioid substance use, or treatment features.</p><p><strong>Methods: </strong>From December 2012 to December 2014, this program enrolled 70 patients who were discharged from other clinics in the area; we were their last remaining option for methadone treatment. Unlike the clinic's standard policies, the treatment focus for SC patients was retention rather than abstinence. This program focused on connection to care (eg, psychiatric services) and enabled patients to continue receiving services despite ongoing substance use. Each patient was assessed at treatment entry and followed until June 2016 to evaluate outcomes.</p><p><strong>Results: </strong>SC patients receiving disability benefits (n = 37) vs. non-disabled (n = 33) had significantly (<i>P</i> < .05) higher rates of current DSM-IV Axis I psychiatric diagnosis (97% vs 70%), prescriptions for opioids (84% vs 55%) and benzodiazepines (65% vs 27%), and higher methadone doses at admission (58 vs 46 mg) but did not differ significantly in rates of 6-month or 1-year retention (77% and 56%, respectively) or all-drug use (39% positive urine drug screens). Methadone doses >65 mg predicted significantly longer retention and less opioid use, but these effects were not moderated by baseline characteristics.</p><p><strong>Conclusions: </strong>Patients in methadone treatment struggling to achieve abstinence may benefit from retention-oriented harm-reduction programs. Higher methadone doses can improve retention and opioid abstinence despite psychiatric comorbidities. Further work is needed to improve program implementation and outcomes in this complex population.</p>","PeriodicalId":22185,"journal":{"name":"Substance Abuse: Research and Treatment","volume":"16 ","pages":"11782218221138335"},"PeriodicalIF":2.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3f/54/10.1177_11782218221138335.PMC9669697.pdf","citationCount":"0","resultStr":"{\"title\":\"Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty \\\"Second Chance\\\" Methadone Program.\",\"authors\":\"Tabitha E Moses,&nbsp;Gary L Rhodes,&nbsp;Emytis Tavakoli,&nbsp;Carl W Christensen,&nbsp;Alireza Amirsadri,&nbsp;Mark K Greenwald\",\"doi\":\"10.1177/11782218221138335\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Many patients in methadone treatment have difficulty achieving or maintaining drug abstinence, and many clinics have policies that lead to discharging these patients. We designed a pilot \\\"Second Chance\\\" (SC) program for patients scheduled to be discharged from other local methadone clinics to be transferred to our clinic.</p><p><strong>Aim: </strong>Determine whether SC patients' retention and opioid use is related to physical or mental health conditions, non-opioid substance use, or treatment features.</p><p><strong>Methods: </strong>From December 2012 to December 2014, this program enrolled 70 patients who were discharged from other clinics in the area; we were their last remaining option for methadone treatment. Unlike the clinic's standard policies, the treatment focus for SC patients was retention rather than abstinence. This program focused on connection to care (eg, psychiatric services) and enabled patients to continue receiving services despite ongoing substance use. Each patient was assessed at treatment entry and followed until June 2016 to evaluate outcomes.</p><p><strong>Results: </strong>SC patients receiving disability benefits (n = 37) vs. non-disabled (n = 33) had significantly (<i>P</i> < .05) higher rates of current DSM-IV Axis I psychiatric diagnosis (97% vs 70%), prescriptions for opioids (84% vs 55%) and benzodiazepines (65% vs 27%), and higher methadone doses at admission (58 vs 46 mg) but did not differ significantly in rates of 6-month or 1-year retention (77% and 56%, respectively) or all-drug use (39% positive urine drug screens). Methadone doses >65 mg predicted significantly longer retention and less opioid use, but these effects were not moderated by baseline characteristics.</p><p><strong>Conclusions: </strong>Patients in methadone treatment struggling to achieve abstinence may benefit from retention-oriented harm-reduction programs. Higher methadone doses can improve retention and opioid abstinence despite psychiatric comorbidities. Further work is needed to improve program implementation and outcomes in this complex population.</p>\",\"PeriodicalId\":22185,\"journal\":{\"name\":\"Substance Abuse: Research and Treatment\",\"volume\":\"16 \",\"pages\":\"11782218221138335\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3f/54/10.1177_11782218221138335.PMC9669697.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Substance Abuse: Research and Treatment\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/11782218221138335\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"SUBSTANCE ABUSE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Substance Abuse: Research and Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/11782218221138335","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0

摘要

背景:许多接受美沙酮治疗的患者难以达到或维持药物戒断,许多诊所有导致这些患者出院的政策。我们设计了一个试点“第二次机会”(SC)计划,让从其他当地美沙酮诊所出院的患者转到我们的诊所。目的:确定SC患者的滞留和阿片类药物使用是否与身体或精神健康状况、非阿片类物质使用或治疗特征有关。方法:2012年12月至2014年12月,选取本区其他门诊出院患者70例;我们是他们美沙酮治疗的最后选择。与诊所的标准政策不同,SC患者的治疗重点是保留而不是禁欲。该项目侧重于与护理(如精神科服务)的联系,并使患者能够在持续使用药物的情况下继续接受服务。每位患者在治疗开始时进行评估,并随访至2016年6月以评估结果。结果:接受残疾福利的SC患者(n = 37)与未残疾的SC患者(n = 33)相比,p65 mg预测的滞留时间更长,阿片类药物使用更少,但这些影响并没有被基线特征所缓和。结论:美沙酮治疗中难以戒断的患者可能受益于以保留为导向的危害减少计划。高剂量的美沙酮可以改善滞留和阿片类药物戒断,尽管精神合并症。在这一复杂的人群中,需要进一步的工作来改善方案的实施和结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty "Second Chance" Methadone Program.

Background: Many patients in methadone treatment have difficulty achieving or maintaining drug abstinence, and many clinics have policies that lead to discharging these patients. We designed a pilot "Second Chance" (SC) program for patients scheduled to be discharged from other local methadone clinics to be transferred to our clinic.

Aim: Determine whether SC patients' retention and opioid use is related to physical or mental health conditions, non-opioid substance use, or treatment features.

Methods: From December 2012 to December 2014, this program enrolled 70 patients who were discharged from other clinics in the area; we were their last remaining option for methadone treatment. Unlike the clinic's standard policies, the treatment focus for SC patients was retention rather than abstinence. This program focused on connection to care (eg, psychiatric services) and enabled patients to continue receiving services despite ongoing substance use. Each patient was assessed at treatment entry and followed until June 2016 to evaluate outcomes.

Results: SC patients receiving disability benefits (n = 37) vs. non-disabled (n = 33) had significantly (P < .05) higher rates of current DSM-IV Axis I psychiatric diagnosis (97% vs 70%), prescriptions for opioids (84% vs 55%) and benzodiazepines (65% vs 27%), and higher methadone doses at admission (58 vs 46 mg) but did not differ significantly in rates of 6-month or 1-year retention (77% and 56%, respectively) or all-drug use (39% positive urine drug screens). Methadone doses >65 mg predicted significantly longer retention and less opioid use, but these effects were not moderated by baseline characteristics.

Conclusions: Patients in methadone treatment struggling to achieve abstinence may benefit from retention-oriented harm-reduction programs. Higher methadone doses can improve retention and opioid abstinence despite psychiatric comorbidities. Further work is needed to improve program implementation and outcomes in this complex population.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.70
自引率
4.80%
发文量
50
审稿时长
8 weeks
期刊最新文献
The Role of Substance Use Disorders on Suicidal Ideation, Planning, and Attempts: A Nationally Representative Study of Adolescents and Adults in the United States, 2020. Reconsidering the Terminology: Study Participants as "Subjects" or Not? Recovering Individuals' Feelings About Addict and Alcoholic as Stigmatized Terms: Implications for Treatment. Untrained Bystanders Administering Drone-Delivered Naloxone: An Exploratory Study. Integrated Supports for Women and Girls Experiencing Substance Use and Complex Needs.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1